The cGAS-STING pathway in ischemia-reperfusion injury in acute cerebral infarction: a new therapeutic opportunities?

被引:0
|
作者
Hu, Jun [1 ]
Tian, Mengxiang [2 ]
机构
[1] Yunnan Univ, Affiliated Hosp, Dept Rehabil Med, Kunming, Peoples R China
[2] Cent South Univ, Xiangya Hosp, Dept Gen Surg, Changsha, Hunan, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
cGAS-STING pathway; acute cerebral infarction; ischemia-reperfusion; cGAS-STING inhibitor; application of nanomaterials; ISCHEMIA/REPERFUSION INJURY; STROKE; MANAGEMENT;
D O I
10.3389/fneur.2024.1471287
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The innate immune response is the body's first line of defense against external pathogens and endogenous damage signals. The cGAS-STING pathway is a crucial component of the innate immune response, playing a key role in initiating antiviral and anti-infective immune responses by recognizing cytosolic DNA. Acute cerebral infarction is one of the leading causes of death and disability worldwide, with the primary treatment approach being the restoration of blood flow to ischemic brain tissue. However, reperfusion injury remains a significant challenge during treatment. The overactivation of the cGAS-STING pathway and its association with ischemia-reperfusion injury have been confirmed in numerous studies. This article will systematically elucidate the mechanisms of the cGAS-STING pathway, its role in ischemia-reperfusion injury in acute cerebral infarction, the current research status of cGAS-STING inhibitors, and the application of nanomaterials in this context, evaluating the therapeutic potential of this pathway.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury
    Chen, Xing-miao
    Chen, Han-sen
    Xu, Ming-jing
    Shen, Jian-gang
    ACTA PHARMACOLOGICA SINICA, 2013, 34 (01) : 67 - 77
  • [42] Stimulator of interferon genes (STING): Key therapeutic targets in ischemia/reperfusion injury
    Lv, Juan
    Zhu, Xuanxuan
    Xing, Chunlei
    Chen, Yuhong
    Bian, Huihui
    Yin, Heng
    Gu, Xiaofeng
    Su, Li
    BIOMEDICINE & PHARMACOTHERAPY, 2023, 167
  • [43] Targeting reactive nitrogen species: a promising therapeutic strategy for cerebral ischemia-reperfusion injury
    Xing-miao Chen
    Han-sen Chen
    Ming-jing Xu
    Jian-gang Shen
    Acta Pharmacologica Sinica, 2013, 34 : 67 - 77
  • [44] Emerging Treatment Strategies for Cerebral Ischemia-Reperfusion Injury
    Li, Mengxing
    Tang, Heyong
    Li, Zhen
    Tang, Wei
    NEUROSCIENCE, 2022, 507 : 112 - 124
  • [45] The Role of Cullin 3 in Cerebral Ischemia-Reperfusion Injury
    Chen, Nan
    Liu, Yushuang
    Yu, Hongyi
    Liu, Sihan
    Xiao, Peng
    Jia, Zhongyi
    Zhang, Zhongling
    NEUROSCIENCE, 2023, 514 : 14 - 24
  • [46] Mitochondrial Quality Control in Cerebral Ischemia-Reperfusion Injury
    Wu, Mimi
    Gu, Xiaoping
    Ma, Zhengliang
    MOLECULAR NEUROBIOLOGY, 2021, 58 (10) : 5253 - 5271
  • [47] Protective effect of polysaccharide peptide on cerebral ischemia-reperfusion injury in rats
    Xing, Pengcheng
    Ma, Ke
    Wu, Jun
    Long, Wei
    Wang, Donglian
    MOLECULAR MEDICINE REPORTS, 2018, 18 (06) : 5371 - 5378
  • [48] Proteomic analysis of Biliverdin protected cerebral ischemia-reperfusion injury in rats
    Bai, Wenya
    Huo, Siying
    Li, Junjie
    Yang, Yuan
    Zhou, Guilin
    Shao, Jianlin
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [49] Therapeutic effect of bFGF on retina ischemia-reperfusion injury
    Niu, YJ
    Zhao, YS
    Gao, YX
    Zhou, ZY
    Wang, HY
    Yuan, CY
    CHINESE MEDICAL JOURNAL, 2004, 117 (02) : 252 - 257
  • [50] Osmundacetone Alleviates Cerebral Ischemia-Reperfusion Injury in Rats
    Li, Bowen
    Yu, Wentao
    Yang, Lan
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2023, 46 (11) : 1527 - 1534